Final answer:
Before starting treatment with Jardiance, a healthcare professional should assess the patient's renal function and volume status to avoid possible side effects and complications.
Step-by-step explanation:
Assess renal function and volume status before initiating Jardiance and as clinically indicated. Jardiance (empagliflozin) is a medication used to treat type 2 diabetes. Before initiating treatment, it's crucial to evaluate the patient's renal function due to the drug's mechanism of action which involves the kidneys. Patients with impaired renal function may have an increased risk of adverse effects, including the risk of ketoacidosis and dehydration.
Volume status should also be evaluated as this medication causes diuresis, which can lead to a decrease in blood volume and subsequent hypotension. Adjustments in dosage or an alternative treatment may be warranted based on these assessments.